Cardiac Lymphoma: A Rare Cause of Acute Heart Failure with Restrictive Physiology

Garagoli, Fernando; Guzzetti, Ezéquiel; Lillo, Ezequiel; Lucas, Luciano; Belziti, César

doi:10.5935/abc.20180015

Arquivos Brasileiros De Cardiologia

2018

DOI: 10.5935/abc.20180015

|View full text |Cite

Cardiac Lymphoma: A Rare Cause of Acute Heart Failure with Restrictive Physiology

Fernando Garagoli

Ezéquiel Guzzetti

Ezequiel Lillo

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2020

2023

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The short tau inversion recovery (T2 STIR) sequences ( Supplementary material online , Figure S2D ) showed high contrast enhancement, consistent for oedema and hypervascularization of the mass. Besides, phase-sensitive inversion recovery (T1 PSIR) sequences ( Supplementary material online , Figure S2C ) revealed a heterogeneous pattern of late gadolinium enhancement, indicating intralesional fibrosis and/or necrosis 2 3 .…”

mentioning

confidence: 99%

A massive intracardiac localization of a non-Hodgkin lymphoma: a multimodality-approach diagnosis

Vita

Petullà

Cerchiello

et al. 2020

European Heart Journal - Case Reports

View full text Add to dashboard Cite

mentioning

confidence: 99%

A massive intracardiac localization of a non-Hodgkin lymphoma: a multimodality-approach diagnosis

Vita

Petullà

Cerchiello

et al. 2020

European Heart Journal - Case Reports

View full text Add to dashboard Cite

Multiparametric mapping by cardiovascular magnetic resonance imaging in cardiac tumors

Yue

Wan

et al. 2023

Journal of Cardiovascular Magnetic Resonance

View full text Add to dashboard Cite

Background There is a paucity of quantitative measurements of cardiac tumors and myocardium using parametric mapping techniques. This study aims to explore quantitative characteristics and diagnostic performance of native T1, T2, and extracellular volume (ECV) values of cardiac tumors and left ventricular (LV) myocardium. Methods Patients with suspected cardiac tumors who underwent cardiovascular magnetic resonance (CMR) between November 2013 and March 2021 were prospectively enrolled. The diagnoses of primary benign or malignant tumors were based on pathologic findings if available, comprehensive medical history evaluations, imaging, and long-term follow-up data. Patients with pseudo-tumors, cardiac metastasis, primary cardiac diseases, and prior radiotherapy or chemotherapy were excluded. Multiparametric mapping values were measured on both cardiac tumors and the LV myocardium. Statistical analyses were performed using independent-samples t-test, receiver operating characteristic, and Bland–Altman analyses. Results A total of 80 patients diagnosed with benign (n = 54), or primary malignant cardiac tumors (n = 26), and 50 age and sex-matched healthy volunteers were included. Intergroup differences in the T1 and T2 values of cardiac tumors were not significant, however, patients with primary malignant cardiac tumors showed significantly higher mean myocardial T1 values (1360 ± 61.4 ms) compared with patients with benign tumors (1259.7 ± 46.2 ms), and normal controls (1206 ± 44.0 ms, all P < 0.05) at 3 T. Patients with primary malignant cardiac tumors also showed significantly higher mean ECV (34.6 ± 5.2%) compared with patients with benign (30.0 ± 2.5%) tumors, and normal controls (27.3 ± 3.0%, all P < 0.05). For the differentiation between primary malignant and benign cardiac tumors, the mean myocardial native T1 value showed the highest efficacy (AUC: 0.919, cutoff value: 1300 ms) compared with mean ECV (AUC: 0.817) and T2 (AUC: 0.619) values. Conclusion Native T1 and T2 of cardiac tumors showed high heterogeneity, while myocardial native T1 values in primary malignant cardiac tumors were elevated compared to patients with benign cardiac tumors, which may serve as a new imaging marker for primary malignant cardiac tumors.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Cardiac Lymphoma: A Rare Cause of Acute Heart Failure with Restrictive Physiology

Cited by 2 publications

References 0 publications

A massive intracardiac localization of a non-Hodgkin lymphoma: a multimodality-approach diagnosis

A massive intracardiac localization of a non-Hodgkin lymphoma: a multimodality-approach diagnosis

Multiparametric mapping by cardiovascular magnetic resonance imaging in cardiac tumors

Contact Info

Product

Resources

About